{"id":20069,"date":"2024-02-29T16:12:51","date_gmt":"2024-02-29T05:12:51","guid":{"rendered":"https:\/\/mvec.mcri.edu.au\/?p=20069"},"modified":"2024-02-29T16:12:51","modified_gmt":"2024-02-29T05:12:51","slug":"atagi-statement-on-the-clinical-use-of-arexvy","status":"publish","type":"post","link":"https:\/\/mvec.mcri.edu.au\/vi\/atagi-statement-on-the-clinical-use-of-arexvy\/","title":{"rendered":"ATAGI: Statement on the clinical use of Arexvy"},"content":{"rendered":"<p><span data-contrast=\"auto\">ATAGI (Australian Technical Advisory Group on Immunisation) has published a statement on the clinical use of Arexvy, a respiratory syncytial virus (RSV) vaccine, for the prevention of RSV in older adults in Australia.<\/span><span data-ccp-props=\"{}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"none\">Respiratory syncytial virus (RSV) is one of the leading causes of respiratory tract infections in young children and is\u00a0associated with severe respiratory disease in people aged over 60 years.\u00a0<\/span> <span data-ccp-props=\"{}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"auto\">Arexvy is available on the private market, and is recommended for:<\/span><span data-ccp-props=\"{}\">\u00a0<\/span><\/p>\n<ul>\n<li data-leveltext=\"\uf0b7\" data-font=\"Symbol\" data-listid=\"4\" data-list-defn-props=\"{&quot;335552541&quot;:1,&quot;335559683&quot;:0,&quot;335559684&quot;:-2,&quot;335559685&quot;:720,&quot;335559991&quot;:360,&quot;469769226&quot;:&quot;Symbol&quot;,&quot;469769242&quot;:[8226],&quot;469777803&quot;:&quot;left&quot;,&quot;469777804&quot;:&quot;\uf0b7&quot;,&quot;469777815&quot;:&quot;hybridMultilevel&quot;}\" aria-setsize=\"-1\" data-aria-posinset=\"1\" data-aria-level=\"1\"><span data-contrast=\"auto\">all adults aged over 75 years<\/span><span data-ccp-props=\"{}\">\u00a0<\/span><\/li>\n<li data-leveltext=\"\uf0b7\" data-font=\"Symbol\" data-listid=\"4\" data-list-defn-props=\"{&quot;335552541&quot;:1,&quot;335559683&quot;:0,&quot;335559684&quot;:-2,&quot;335559685&quot;:720,&quot;335559991&quot;:360,&quot;469769226&quot;:&quot;Symbol&quot;,&quot;469769242&quot;:[8226],&quot;469777803&quot;:&quot;left&quot;,&quot;469777804&quot;:&quot;\uf0b7&quot;,&quot;469777815&quot;:&quot;hybridMultilevel&quot;}\" aria-setsize=\"-1\" data-aria-posinset=\"1\" data-aria-level=\"1\"><span data-contrast=\"auto\">First Nations Australians aged 60 to 74 years<\/span><span data-ccp-props=\"{}\">\u00a0<\/span><\/li>\n<li data-leveltext=\"\uf0b7\" data-font=\"Symbol\" data-listid=\"4\" data-list-defn-props=\"{&quot;335552541&quot;:1,&quot;335559683&quot;:0,&quot;335559684&quot;:-2,&quot;335559685&quot;:720,&quot;335559991&quot;:360,&quot;469769226&quot;:&quot;Symbol&quot;,&quot;469769242&quot;:[8226],&quot;469777803&quot;:&quot;left&quot;,&quot;469777804&quot;:&quot;\uf0b7&quot;,&quot;469777815&quot;:&quot;hybridMultilevel&quot;}\" aria-setsize=\"-1\" data-aria-posinset=\"1\" data-aria-level=\"1\"><span data-contrast=\"auto\">Non-Indigenous Australians with medical conditions that increase their risk of severe disease due to RSV.<\/span><span data-ccp-props=\"{}\">\u00a0<\/span><\/li>\n<\/ul>\n<p><span data-contrast=\"auto\">ATAGI\u2019s full statement includes further details on recommendations, contraindications, coadministration, RSV and Arexvy.<\/span><\/p>\n<p><span data-contrast=\"auto\">A new chapter on RSV will be available in the Australian Immunisation Handbook by mid-2024. Until then, use the ATAGI statement for clinical guidance.<\/span><span data-ccp-props=\"{}\">\u00a0<\/span><\/p>\n<p><a href=\"https:\/\/www.health.gov.au\/resources\/publications\/atagi-statement-on-the-clinical-use-of-arexvy-rsv-pre-f3-vaccine-for-rsv?language=en#:~:text=ATAGI%20has%20provided%20clinical%20advice,with%20respiratory%20syncytial%20virus%20infection.&amp;text=We%20aim%20to%20provide%20documents%20in%20an%20accessible%20format\" target=\"_blank\" rel=\"noopener\"><span data-contrast=\"auto\">ATAGI: Statement on the clinical use of Arexvy<\/span><\/a><\/p>\n<p><a href=\"https:\/\/mvec.mcri.edu.au\/references\/respiratory-syncytial-virus-rsv\/\"><span data-contrast=\"auto\">MVEC: RSV<\/span><\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>ATAGI (Australian Technical Advisory Group on Immunisation) has published a statement on the clinical use of Arexvy, a respiratory syncytial virus (RSV) vaccine, for the prevention of RSV in older adults in Australia.\u00a0<\/p>","protected":false},"author":493,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_lmt_disableupdate":"no","_lmt_disable":"","footnotes":"","_wp_rev_ctl_limit":""},"categories":[87,10],"tags":[],"class_list":["post-20069","post","type-post","status-publish","format-standard","hentry","category-news","category-external"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>ATAGI: Statement on the clinical use of Arexvy - The Melbourne Vaccine Education Centre (MVEC)<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/mvec.mcri.edu.au\/vi\/atagi-statement-on-the-clinical-use-of-arexvy\/\" \/>\n<meta property=\"og:locale\" content=\"vi_VN\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ATAGI: Statement on the clinical use of Arexvy - The Melbourne Vaccine Education Centre (MVEC)\" \/>\n<meta property=\"og:description\" content=\"ATAGI (Australian Technical Advisory Group on Immunisation) has published a statement on the clinical use of Arexvy, a respiratory syncytial virus (RSV) vaccine, for the prevention of RSV in older adults in Australia.\u00a0\" \/>\n<meta property=\"og:url\" content=\"https:\/\/mvec.mcri.edu.au\/vi\/atagi-statement-on-the-clinical-use-of-arexvy\/\" \/>\n<meta property=\"og:site_name\" content=\"The Melbourne Vaccine Education Centre (MVEC)\" \/>\n<meta property=\"article:published_time\" content=\"2024-02-29T05:12:51+00:00\" \/>\n<meta name=\"author\" content=\"Alice Black\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u0110\u01b0\u1ee3c vi\u1ebft b\u1edfi\" \/>\n\t<meta name=\"twitter:data1\" content=\"Alice Black\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u01af\u1edbc t\u00ednh th\u1eddi gian \u0111\u1ecdc\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 ph\u00fat\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/mvec.mcri.edu.au\\\/atagi-statement-on-the-clinical-use-of-arexvy\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/mvec.mcri.edu.au\\\/atagi-statement-on-the-clinical-use-of-arexvy\\\/\"},\"author\":{\"name\":\"Alice Black\",\"@id\":\"https:\\\/\\\/mvec.mcri.edu.au\\\/#\\\/schema\\\/person\\\/b6f69ebc60314c6d952badec26f9c311\"},\"headline\":\"ATAGI: Statement on the clinical use of Arexvy\",\"datePublished\":\"2024-02-29T05:12:51+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/mvec.mcri.edu.au\\\/atagi-statement-on-the-clinical-use-of-arexvy\\\/\"},\"wordCount\":155,\"articleSection\":[\"Show all\",\"External News\"],\"inLanguage\":\"vi\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/mvec.mcri.edu.au\\\/atagi-statement-on-the-clinical-use-of-arexvy\\\/\",\"url\":\"https:\\\/\\\/mvec.mcri.edu.au\\\/atagi-statement-on-the-clinical-use-of-arexvy\\\/\",\"name\":\"ATAGI: Statement on the clinical use of Arexvy - The Melbourne Vaccine Education Centre (MVEC)\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/mvec.mcri.edu.au\\\/#website\"},\"datePublished\":\"2024-02-29T05:12:51+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/mvec.mcri.edu.au\\\/#\\\/schema\\\/person\\\/b6f69ebc60314c6d952badec26f9c311\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/mvec.mcri.edu.au\\\/atagi-statement-on-the-clinical-use-of-arexvy\\\/#breadcrumb\"},\"inLanguage\":\"vi\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/mvec.mcri.edu.au\\\/atagi-statement-on-the-clinical-use-of-arexvy\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/mvec.mcri.edu.au\\\/atagi-statement-on-the-clinical-use-of-arexvy\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/mvec.mcri.edu.au\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ATAGI: Statement on the clinical use of Arexvy\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/mvec.mcri.edu.au\\\/#website\",\"url\":\"https:\\\/\\\/mvec.mcri.edu.au\\\/\",\"name\":\"The Melbourne Vaccine Education Centre (MVEC)\",\"description\":\"Find all your vaccine related infos here.\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/mvec.mcri.edu.au\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"vi\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/mvec.mcri.edu.au\\\/#\\\/schema\\\/person\\\/b6f69ebc60314c6d952badec26f9c311\",\"name\":\"Alice Black\",\"url\":\"https:\\\/\\\/mvec.mcri.edu.au\\\/vi\\\/author\\\/alice-black\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ATAGI: Statement on the clinical use of Arexvy - The Melbourne Vaccine Education Centre (MVEC)","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/mvec.mcri.edu.au\/vi\/atagi-statement-on-the-clinical-use-of-arexvy\/","og_locale":"vi_VN","og_type":"article","og_title":"ATAGI: Statement on the clinical use of Arexvy - The Melbourne Vaccine Education Centre (MVEC)","og_description":"ATAGI (Australian Technical Advisory Group on Immunisation) has published a statement on the clinical use of Arexvy, a respiratory syncytial virus (RSV) vaccine, for the prevention of RSV in older adults in Australia.\u00a0","og_url":"https:\/\/mvec.mcri.edu.au\/vi\/atagi-statement-on-the-clinical-use-of-arexvy\/","og_site_name":"The Melbourne Vaccine Education Centre (MVEC)","article_published_time":"2024-02-29T05:12:51+00:00","author":"Alice Black","twitter_card":"summary_large_image","twitter_misc":{"\u0110\u01b0\u1ee3c vi\u1ebft b\u1edfi":"Alice Black","\u01af\u1edbc t\u00ednh th\u1eddi gian \u0111\u1ecdc":"1 ph\u00fat"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/mvec.mcri.edu.au\/atagi-statement-on-the-clinical-use-of-arexvy\/#article","isPartOf":{"@id":"https:\/\/mvec.mcri.edu.au\/atagi-statement-on-the-clinical-use-of-arexvy\/"},"author":{"name":"Alice Black","@id":"https:\/\/mvec.mcri.edu.au\/#\/schema\/person\/b6f69ebc60314c6d952badec26f9c311"},"headline":"ATAGI: Statement on the clinical use of Arexvy","datePublished":"2024-02-29T05:12:51+00:00","mainEntityOfPage":{"@id":"https:\/\/mvec.mcri.edu.au\/atagi-statement-on-the-clinical-use-of-arexvy\/"},"wordCount":155,"articleSection":["Show all","External News"],"inLanguage":"vi"},{"@type":"WebPage","@id":"https:\/\/mvec.mcri.edu.au\/atagi-statement-on-the-clinical-use-of-arexvy\/","url":"https:\/\/mvec.mcri.edu.au\/atagi-statement-on-the-clinical-use-of-arexvy\/","name":"ATAGI: Statement on the clinical use of Arexvy - The Melbourne Vaccine Education Centre (MVEC)","isPartOf":{"@id":"https:\/\/mvec.mcri.edu.au\/#website"},"datePublished":"2024-02-29T05:12:51+00:00","author":{"@id":"https:\/\/mvec.mcri.edu.au\/#\/schema\/person\/b6f69ebc60314c6d952badec26f9c311"},"breadcrumb":{"@id":"https:\/\/mvec.mcri.edu.au\/atagi-statement-on-the-clinical-use-of-arexvy\/#breadcrumb"},"inLanguage":"vi","potentialAction":[{"@type":"ReadAction","target":["https:\/\/mvec.mcri.edu.au\/atagi-statement-on-the-clinical-use-of-arexvy\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/mvec.mcri.edu.au\/atagi-statement-on-the-clinical-use-of-arexvy\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/mvec.mcri.edu.au\/"},{"@type":"ListItem","position":2,"name":"ATAGI: Statement on the clinical use of Arexvy"}]},{"@type":"WebSite","@id":"https:\/\/mvec.mcri.edu.au\/#website","url":"https:\/\/mvec.mcri.edu.au\/","name":"Trung t\u00e2m gi\u00e1o d\u1ee5c v\u1eafc xin Melbourne (MVEC)","description":"T\u00ecm t\u1ea5t c\u1ea3 c\u00e1c th\u00f4ng tin li\u00ean quan \u0111\u1ebfn v\u1eafc-xin c\u1ee7a b\u1ea1n \u1edf \u0111\u00e2y.","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/mvec.mcri.edu.au\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"vi"},{"@type":"Person","@id":"https:\/\/mvec.mcri.edu.au\/#\/schema\/person\/b6f69ebc60314c6d952badec26f9c311","name":"Alice \u0111en","url":"https:\/\/mvec.mcri.edu.au\/vi\/author\/alice-black\/"}]}},"modified_by":"Alice Black","_links":{"self":[{"href":"https:\/\/mvec.mcri.edu.au\/vi\/wp-json\/wp\/v2\/posts\/20069","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mvec.mcri.edu.au\/vi\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mvec.mcri.edu.au\/vi\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mvec.mcri.edu.au\/vi\/wp-json\/wp\/v2\/users\/493"}],"replies":[{"embeddable":true,"href":"https:\/\/mvec.mcri.edu.au\/vi\/wp-json\/wp\/v2\/comments?post=20069"}],"version-history":[{"count":0,"href":"https:\/\/mvec.mcri.edu.au\/vi\/wp-json\/wp\/v2\/posts\/20069\/revisions"}],"wp:attachment":[{"href":"https:\/\/mvec.mcri.edu.au\/vi\/wp-json\/wp\/v2\/media?parent=20069"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mvec.mcri.edu.au\/vi\/wp-json\/wp\/v2\/categories?post=20069"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mvec.mcri.edu.au\/vi\/wp-json\/wp\/v2\/tags?post=20069"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}